OTIVIO
Otivio AS is a privately owned company based in Oslo, Norway. The company was founded in 2010 based on IP, prototypes and clinical data developed at University of Oslo. Otivio is ISO 13485 certified. The core technology enables increased blood flow to the limbs of a patient. Otivio’s main product, FlowOx™, is addressing peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very lar... ge and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Early long-term patient testing documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked.
OTIVIO
Industry:
Biotechnology Health Care Health Diagnostics Medical Device
Founded:
2010-01-01
Address:
Oslo, Oslo, Norway
Country:
Norway
Website Url:
http://www.otivio.com
Total Employee:
1+
Status:
Active
Total Funding:
27 M NOK
Technology used in webpage:
SPF Microsoft Exchange Online Microsoft Azure DNS One.com DNS One.com
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
iXensor
The pioneer of mobile health
Current Employees Featured
Founder
Official Site Inspections
http://www.otivio.com
- Host name: 195.47.247.19
- IP address: 195.47.247.19
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
